Quantum Biopharma earnings were -$9.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest QNTM earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.7M, up 32.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, QNTM reported annual earnings of -$9.9M, with -26.7% growth. The next QNTM earnings date is May 12, 2025.
What were Quantum Biopharma's earnings last quarter?
Quantum Biopharma (NASDAQ: QNTM) reported Q4 2024 earnings per share (EPS) of -$1.43, up 31.04% year over year. Total QNTM earnings for the quarter were -$3.72 million. In the same quarter last year, Quantum Biopharma's earnings per share (EPS) was -$2.08.
The next QNTM earnings call is Invalid Date. Add QNTM to your watchlist to be reminded of Quantum Biopharma's next earnings date.
What was QNTM's earnings growth in the past year?
As of Quantum Biopharma's earnings date in Q2 2025, Quantum Biopharma's earnings has grown year over year. QNTM earnings in the past year totalled -$9.86 million.
Is Quantum Biopharma profitable or losing money?
As of the last Quantum Biopharma earnings report, Quantum Biopharma is currently losing money. Quantum Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$9.86 million, a 26.73% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.